Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2106 of 6351
-
New laser camera could revolutionize oral cancer diagnosis
Diagnosis Recruiting nowThe purpose of this study is to get images (pictures) of oral lesions, which occur inside the mouth, before the patient's surgery using a special camera. These pictures will be used in our research to evaluate a new technology that uses a laser and takes pictures of the microscop…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Could a transplant drug slow muscle decline in rare disease?
Disease control CompletedSporadic Inclusion Body Myositis (IBM) is the most frequent inflammatory myopathy in patients over 50. It is a slowly progressive, but today untreatable (notably by classical immunosuppressants) disease. Rapamycin used in organ transplantation blocks the activity of T effector c…
Phase 2/3 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 26, 2026 12:44 UTC
-
Daily aspirin may cut colon cancer risk, new study hints
Prevention OngoingThis research study is investigating the use of aspirin as a potential chemopreventive agent to reduce risk of colorectal cancer
Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Tiny radiation dose may tame eye lymphoma
Disease control OngoingThis phase II trial studies how well ultra low dose orbital radiation therapy works in treating patients with stage I-IV low grade (indolent) B-cell lymphoma or mantle cell lymphoma involving the orbit of the eye (space enclosed by the borders of the eye socket). Orbital radiatio…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug cocktail shows promise for tough bladder cancer
Disease control OngoingThis phase I/II trial studies the side effects and best dose of ixazomib citrate, gemcitabine hydrochloride, and doxorubicin hydrochloride when given together in treating patients with urothelial cancer that has spread to other places in the body (metastatic) or cannot be removed…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Gene-Silencing drug shows promise in Hard-to-Treat cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of EphA2 siRNA in treating patients with solid tumors that have spread to other places in the body and usually cannot be cured or controlled with treatment (advanced) or have come back after a period of improvement (recurr…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
A simple blood test may spot hidden infections in kids with cancer
Diagnosis Stopped earlyFevers raise the concern for serious bacterial infections in pediatric oncology patients receiving chemotherapy. The gold standard for diagnosing bacteremia (bacterial infection of the blood) is a blood culture. However, bacterial growth may not occur for 48 hours or there can be…
Sponsor: CAMC Health System • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
New combo therapy aims to quiet phantom limb pain
Symptom relief OngoingThis is a two-site study that explores the effects of mirror therapy and transcranial Direct Current Stimulation (tDCS, Soterix ©) in a randomized factorial controlled trial in which patients will be assigned to one of four groups: active tDCS and active MT; sham tDCS and active …
Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New antibody combo aims to keep bone cancer at bay
Disease control OngoingThe purpose of this study is to find out what effect an antibody called Humanized 3F8 (Hu3F8) and a drug called GM-CSF have on the patient and whether it can keep the patient in remission longer and/or prevent recurrence of the disease.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could your own cells ease knee arthritis pain?
Disease control Recruiting nowThis is a prospective open-label clinical study of 50 patients to determine safety and treatment potential of autologous cell therapy for pain and inflammation associated with Osteoarthritis of the knee. Follow-up will consist of a larger sample including 4,000 patients.
Phase 2 • Sponsor: VivaTech International, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could your own fat cells ease hip arthritis pain?
Disease control Recruiting nowThis is a prospective open-label clinical study of 50 patients to determine safety and treatment potential of autologous cell therapy for pain and inflammation associated with Osteoarthritis of the hip. Follow-up will consist of a larger sample including 4,000 patients.
Phase 2 • Sponsor: VivaTech International, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Kicking the habit in pregnancy may curb baby weight gain
Prevention Recruiting nowThe objective of this study is to test the effect of smoking cessation in pregnancy or in lactation on preventing rapid infant adiposity gain. Investigators propose a randomized, controlled experiment among smoking pregnant women from 1st prenatal care visit through 6 months of p…
Sponsor: State University of New York at Buffalo • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
Texts and navigators: a new way to get taxi drivers to the doctor?
Knowledge-focused OngoingThe purpose of this study is to compare the effectiveness of providing the usual health fair service and follow-up alone plus additional interventions of Navigation Case Management (NCM) or mobile text messaging (mTECH) and Taxi health Improvement Promoter (TIP). The addition of …
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can an iPad replace morphine for Kids' Post-Surgery pain?
Symptom relief Stopped earlyThe purpose of this study is to determine the clinical effectiveness of presenting iPads (Tablet Based Interactive Distraction) to pediatric patients following tonsillectomies/adenotonsillectomies. This randomized controlled trial compares rescue analgesia administration, pain sc…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can a cooking oil protect the brain in Huntington's?
Disease control CompletedIn the study the investigators plan to include 100 early affected HD patients (5 ≤ UHDRS ≤ 40) in a randomized, double-blind, controlled study in 2 centers (France and the Netherlands). Patients will receive either triheptanoin at 1g/kg of body weight per day (n = 50), or a contr…
Phase 2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Exercise may reverse chemo heart damage in childhood cancer survivors
Disease control CompletedOver 50% of the more than 270,000 childhood cancer survivors in the U.S. have been treated with anthracyclines and thus are at risk of developing cardiotoxicity. The impact of exercise training on LV structure has been extensively studied. Left ventricular hypertrophy and cardiac…
Sponsor: Connecticut Children's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New cocktail targets tough lymphoma
Disease control OngoingThis is a dose-escalation to determine the MTD and/or RPII for combinations of ibrutinib (PCI-32765) plus lenalidomide/rituximab in patients with relapsed/refractory mantle cell lymphoma.
Phase 1 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Creamy addition to preemie diets may shorten hospital stays
Disease control CompletedAt present, widespread use of the human milk-based caloric supplement (cream) has not occurred, particularly in infants with bronchopulmonary dysplasia (BPD), and further data are needed to support its adoption as a standard care practice. The investigators hypothesize that infa…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a 'Flora Transplant' stop recurring vaginal infections?
Disease control OngoingBacterial vaginosis (BV) is the most common vaginal infection in women. It is caused by a vaginal bacterial imbalance. Treatment with antibiotics is the standard of care but there is a high rate of recurrence. Almost half of women successfully treated suffer a recurrence within t…
Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New pill targets brain tumors with IDH mutations
Disease control CompletedThis study evaluates the safety, pharmacokinetics, pharmacodynamics and clinical activity of AG-881 in Gliomas, that harbor an IDH1 and/or IDH2 mutation.
Phase 1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC